AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic
- PMID: 35165271
- PMCID: PMC8844306
- DOI: 10.1038/s41467-022-28529-9
AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic
Abstract
The COVID-19 pandemic has driven demand for integrated genomics, resulting in fast-tracked development of AusTrakka, Australia’s pathogen genomics platform. This facilitated rapid data sharing, democratised access to computational and bioinformatic resources and expertise, and achieved national real-time genomic surveillance.
Conflict of interest statement
The authors declare no competing interests.
Figures

References
-
- The White House. Fact Sheet: Biden Administration Announces $1.7 Billion Investment to Fight COVID-19 Variantshttps://www.whitehouse.gov/briefing-room/statements-releases/2021/04/16/... 16 April 2021.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous